Galactose-deficient IgA1 in African Americans with IgA nephropathy: Serum levels and heritability

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 11, 2010, Pages 2069-2074

  Hastings, M Colleen ^a,b   Moldoveanu, Zina ^c   Julian, Bruce A ^c,d   Novak, Jan ^c   Sanders, John T ^a,b   McGlothan, Kim R ^b   Gharavi, Ali G ^e   Wyatt, Robert J ^a,b  

^a LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE; GALACTOSE DEFICIENT IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HERITABILITY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY BIOPSY; MALE; PATHOGENESIS; PRESCHOOL CHILD; RELATIVE; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; CHILD; FEMALE; GALACTOSE; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HEREDITY; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; PEDIGREE; PHENOTYPE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION; YOUNG ADULT;

EID: 78149319893     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03270410     Document Type: Article

References (32)

1. D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64: 709-727, 1987
2. Borok MZ, Nathoo KJ, Gabriel R, Porter KA: Clinicopathological features of Zimbabwean patients with sustained proteinuria. Cent Afr J Med 43: 152-158, 1997
3. Seedat YK, Nathoo BC, Parag KB, Naiker IP, Ramsaroop R: IgA nephropathy in blacks and Indians of Natal. Nephron 50: 137-141, 1988
4. Galla JH, Kohaut EC, Alexander R, Mestecky J: Racial difference in the prevalence of IgA-associated nephropathies. Lancet 2(8401): 522, 1984
5. Hall YN, Fuentes EF, Chertow GM, Olson JL: Race/ethnicity and disease severity in IgA nephropathy. BMC Nephrol 5: 10, 2004
6. Jennette JC, Wall SD, Wilkman AS: Low incidence of IgA nephropathy in blacks. Kidney Int 28: 944-950, 1985
7. Nair R, Walker PD: Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int 69: 1455-1458, 2006
8. Wyatt RJ, Julian BA, Baehler RW, Stafford CC, McMorrow RG, Ferguson T, Jackson E, Woodford SY, Miller PM, Kritchevsky S: Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994. Central Kentucky Region of the Southeastern United States IgA Nephropathy DATABANK Project. J Am Soc Nephrol 9: 853-858, 1998
9. Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J: Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 119: 1668-1677, 2009
10. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J: Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104: 73-81, 1999
11. Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J: IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 67: 504-513, 2005
12. Lin X, Ding J, Zhu L, Shi S, Jiang L, Zhao M, Zhang H: Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy. Nephrol Dial Transplant 24: 3372-3375, 2009
13. Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J: Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 71: 1148-1154, 2007
14. Shimozato S, Hiki Y, Odani H, Takahashi K, Yamamoto K, Sugiyama S: Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy. Nephrol Dial Transplant 23: 1931-1939, 2008
15. Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, Lifton RP, Mestecky J, Novak J, Julian BA: Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 19: 1008-1014, 2008
16. Wyatt RJ, Julian BA, Bhathena DB, Mitchell BL, Holland NH, Malluche HH: IgA nephropathy: Presentation, clinical course, and prognosis in children and adults. Am J Kidney Dis 4: 192-200, 1984
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
18. Schwartz GJ, Feld LG, Langford DJ: A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 104: 849-854, 1984
19. Almasy L, Blangero J: Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62: 1198-1211, 1998
20. Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J: Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol 22: 2067-2072, 2007 (Pubitemid 350090713)
21. Sehic AM, Gaber LW, Roy S 3rd, Miller PM, Kritchevsky SB, Wyatt RJ: Increased recognition of IgA nephropathy in African-American children. Pediatr Nephrol 11: 435-437, 1997
22. Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R: Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int 51: 244-252, 1997
23. Albandar JM, DeNardin AM, Adesanya MR, Winn DM, Diehl SR: Associations of serum concentrations of IgG, IgA, IgM and interleukin-1beta with early-onset periodontitis classification and race. J Clin Periodontol 29: 421-426, 2002
24. Susskind BM, Kerman RH, Browne BJ, Hartwell BA, Davis BG, Katz SM, Van Buren CT, Kahan BD: The impact of elevated serum IgA and race on primary recipient renal allograft survival. Transplantation 61: 205-211, 1996
25. August P, Leventhal B, Suthanthiran M: Hypertension-induced organ damage in African Americans: Transforming growth factor-beta(1) excess as a mechanism for increased prevalence. Curr Hypertens Rep 2: 184-191, 2000
26. Delaney NL, Esquenazi V, Lucas DP, Zachary AA, Leffell MS: TNF-alpha, TGF-beta, IL-10, IL-6, and INF-gamma alleles among African Americans and Cuban Americans. Report of the ASHI Minority Workshops: Part IV. Hum Immunol 65: 1413-1419, 2004
27. Suthanthiran M, Khanna A, Cukran D, Adhikarla R, Sharma VK, Singh T, August P: Transforming growth factor-beta 1 hyperexpression in African American end-stage renal disease patients. Kidney Int 53: 639-644, 1998
28. Buckley RH, Dees SC, O'Fallon WM: Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy. Pediatrics 41: 600-611, 1968
29. West CD, Hong R, Holland NH: Immunoglobulin levels from the newborn period to adulthood and in immunoglobulin deficiency states. J Clin Invest 41: 2054-2064, 1962
30. Sinniah R: Occurrence of mesangial IgA and IgM deposits in a control necropsy population. J Clin Pathol 36: 276-279, 1983
31. Waldherr R, Rambausek M, Duncker WD, Ritz E: Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant 4: 943-946, 1989
32. Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y: Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63: 2286-2294, 2003